These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 22565006)

  • 21. Repurposing Metformin for Cancer Treatment: A Great Challenge of a Promising Drug.
    Saengboonmee C; Sanlung T; Wongkham S
    Anticancer Res; 2021 Dec; 41(12):5913-5918. PubMed ID: 34848445
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metformin and Anti-Cancer Therapeutics: Hopes for a More Enhanced Armamentarium Against Human Neoplasias?
    Christodoulou MI; Scorilas A
    Curr Med Chem; 2017; 24(1):14-56. PubMed ID: 27604091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial.
    Mitsuhashi A; Kiyokawa T; Sato Y; Shozu M
    Cancer; 2014 Oct; 120(19):2986-95. PubMed ID: 24917306
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Illuminating the diabetes-cancer link.
    Brower V
    J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
    [No Abstract]   [Full Text] [Related]  

  • 26. Metformin and the Gut Microbiome in Diabetes.
    Devaraj S; Venkatachalam A; Chen X
    Clin Chem; 2016 Dec; 62(12):1554-1555. PubMed ID: 27650682
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of aromatase inhibitors in comparison with metformin for neoadjuvant treatment in patients with endometrial cancer].
    Bershteĭn LM; Maksimov SIa; Danilova MA; Gershfel'd ÉD; Boiarkina MP; Khadzhimba AS; Kovalevskiĭ AIu; Turkevich EA; Meshkova IE
    Vopr Onkol; 2011; 57(6):737-41. PubMed ID: 22416390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic switching in the hypoglycemic and antitumor effects of metformin on high glucose induced HepG2 cells.
    Lv Y; Tian N; Wang J; Yang M; Kong L
    J Pharm Biomed Anal; 2018 Jul; 156():153-162. PubMed ID: 29705631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes.
    Pusceddu S; Buzzoni R; Vernieri C; Concas L; Marceglia S; Giacomelli L; Milione M; Leuzzi L; Femia D; Formisano B; Mazzaferro V; de Braud F
    Future Oncol; 2016 May; 12(10):1251-60. PubMed ID: 26890290
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metformin Associated With Improved Outcomes in Diabetic Patients With Laryngeal and Oropharyngeal Carcinoma.
    Ogunsakin A; Infield J; Zuber J; Solomon SS
    Am J Med Sci; 2018 Dec; 356(6):574-575. PubMed ID: 30342717
    [No Abstract]   [Full Text] [Related]  

  • 31. A pharmacist's perspective on metformin use and cancer outcomes.
    Ceacareanu AC
    J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081
    [No Abstract]   [Full Text] [Related]  

  • 32. Increasing attention.
    NicNiocaill B; Williams SD; Gölitz P
    ChemMedChem; 2008 Jan; 3(1):3-5. PubMed ID: 18172911
    [No Abstract]   [Full Text] [Related]  

  • 33. Metformin, an old drug, brings a new era to cancer therapy.
    He H; Ke R; Lin H; Ying Y; Liu D; Luo Z
    Cancer J; 2015; 21(2):70-4. PubMed ID: 25815846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Metformin, an antidiabetic molecule with anti-cancer properties].
    Beck E; Scheen AJ
    Rev Med Liege; 2013 Sep; 68(9):444-9. PubMed ID: 24180199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Editorial: Relationship Between Cancers and Diseases with Insulin Resistance.
    He J
    Curr Pharm Des; 2017; 23(25):3627-3628. PubMed ID: 29022507
    [No Abstract]   [Full Text] [Related]  

  • 36. Metformin and incident breast cancer among diabetic women: a population-based case-control study in Denmark.
    Bosco JL; Antonsen S; Sørensen HT; Pedersen L; Lash TL
    Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):101-11. PubMed ID: 21119073
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metformin.
    Nurs Times; 2005 Oct 4-10; 101(40):37-8. PubMed ID: 16250540
    [No Abstract]   [Full Text] [Related]  

  • 38. Using Boolean Logic Modeling of Gene Regulatory Networks to Exploit the Links Between Cancer and Metabolism for Therapeutic Purposes.
    Arshad OA; Venkatasubramani PS; Datta A; Venkatraj J
    IEEE J Biomed Health Inform; 2016 Jan; 20(1):399-407. PubMed ID: 25389247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metformin: An anti-diabetic drug to fight cancer.
    Daugan M; Dufaÿ Wojcicki A; d'Hayer B; Boudy V
    Pharmacol Res; 2016 Nov; 113(Pt A):675-685. PubMed ID: 27720766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin and breast cancer: an opportunity for pharmacogenetics.
    Cuyàs E; Martin-Castillo B; Menendez JA
    Aging (Albany NY); 2022 Jul; 14(14):5612-5613. PubMed ID: 35852878
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.